Intrinsic sympathomimetic activity: Clinical fact or fiction? (Q40092094)

17 September 2017

1 reference

title

Intrinsic sympathomimetic activity: clinical fact or fiction? (English)

1 reference

17 September 2017

Intrinsic sympathomimetic activity: Clinical fact or fiction? (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Cardiology and cardiovascular medicine

13 August 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

13 August 2023

author name string

S. H. Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6139009

13 August 2023

language of work or name

English

0 references

publication date

1 November 1983

1 reference

17 September 2017

10 November 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6139009

full work available at URL

13 August 2023

https://api.elsevier.com/content/article/PII:0002914983906380?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

https://api.elsevier.com/content/article/PII:0002914983906380?httpAccept=text/plain

13 August 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

American Journal of Cardiology

13 August 2023

published in

1 reference

17 September 2017

volume

52

1 reference

17 September 2017

issue

9

1 reference

17 September 2017

page(s)

16D-26D

1 reference

Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Review of review Partial agonist activity of beta-adrenoceptor blocking drugs

13 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Beta-adrenoceptor-blocking agents: Are pharmacologic differences relevant?

13 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

beta-Adrenoceptor blocking agents as partial agonists in isolated heart muscle: dissociation of stimulation and blockade

13 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Pindolol--the pharmacology of a partial agonist

13 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Comparative chronotropic activity of beta-adrenoceptive antagonists

13 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

A study of the relationship between cardiac ?-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines

13 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

beta-Adrenergic Receptor Subtypes: Properties, Distribution, and Regulation

13 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers

13 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Adrenergic beta receptor blockade: Hemodynamic importance of intrinsic sympathomimetic activity at rest

13 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate

13 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease

13 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?

13 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease

13 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The influence of beta-adrenoceptor blockade on left ventricular function

13 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Acute myocardial infarction: selective or ISA-type beta-adrenoceptor blocking drug?

13 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature

13 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Raynaud's phenomenon as side effect of beta-blockers in hypertension

13 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of acute oral beta adrenergic blockade on muscle blood flow in man

13 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.

13 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism

13 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Studies of cardioselectivity and partial agonist activity in beta- adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise

13 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Quantitative assessment of bronchial beta-adrenoceptor blockade in man

13 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Limitation of Work Performance in Normal Adult Males in the Presence of Beta-Adrenergic Blockade

13 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol

13 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Factors influencing infarct size following experimental coronary artery occlusions

13 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs

13 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of propranolol on mitochondrial morphology during acute myocardial ischemia

13 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Prolonged protective effect of propranolol on hypoxic heart muscle

13 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Beta-blockade and ischaemic injury: effects of partial agonist activity

13 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Long-term beta-blockade: prolonged protective action on the ischaemic myocardium

13 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man

13 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Antihypertensive drugs and blood lipids: the Oslo study

13 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of chronic administration of propranolol on lipoprotein composition

13 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

13 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of propranolol and prazosin on blood lipids. The Oslo Study

13 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Long-term Effect of Sotalol on Plasma Lipids

13 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man

13 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

13 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

13 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The metabolic consequences of adrenergic blockade: A review

13 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Metabolic effects of beta-adrenoreceptor blockers

13 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Hypoglycaemia precipitated by propranolol

13 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Comparison of atenolol and propranolol during insulin-induced hypoglycaemia

13 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics

13 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

13 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of adrenergic blocking agents on insulin response to glucose infusion in man

13 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension

13 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol

13 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia

13 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics

13 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Role of glucagon and other hormones in development of diabetic ketoacidosis

13 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effect of Metabolic Control on Urinary Excretion and Plasma Levels of Catecholamines in Diabetics

13 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Chronic autonomic failure with postural hypotension

13 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Defective cardiovascular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure

13 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy

13 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Pindolol in postural hypotension

13 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Pharmacologic distinction of different orthostatic hypotension syndromes

13 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Beta-receptors in orthostatic hypotension

13 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs

13 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin

13 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Beta-blocker withdrawal syndrome

13 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Coronary artery syndromes after sudden propranolol withdrawal

13 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

13 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Acute coronary syndromes following abrupt cessation of oral propranolol therapy

13 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol

13 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Elevated beta-adrenergic receptor number after chronic propranolol treatment

13 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration

13 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects

13 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Hyperthyroidism After Propranolol Withdrawal

13 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Propranolol withdrawal and thyroid hormones in patients with essential hypertension

13 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal

13 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Abrupt propranolol withdrawal in angina pectoris: Effects on platelet aggregation and exercise tolerance

13 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation

13 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2

13 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Trasicor in Angina Pectoris: a Double-blind Trial

13 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

Abrupt withdrawal of pindolol or metoprolol after chronic therapy

13 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0002-9149(83)90638-0

13 August 2023

Identifiers

1 reference

17 September 2017

1 reference